It lets patients help decide what
they actually need...
A new drug
development company, Transparency LifeSciences, is planning to offer an alternative to the normal clinical trial
process—trying to make it more transparent, faster, cheaper, more effective,
more inclusive, and more easily available to patients.
Dr. Tomasz
Sablinski, founder of Transparency Life
Sciences, has been frustrated by the “secrecy” in the clinical trials process.
“The price you pay when you hide what you’re doing is you only get feedback
from a precious few people.” He believes, “You have to add patients to the mix,
because they’re really the reason you’re doing drug development.”
Dr. Sablinski is recruiting patients, physicians,
and scientists—online—to share information, offer suggestions, and help create
and launch this new, open type of clinical trial. Information and results will
be available to everyone—whether the results are negative or positive.
